Last €3.09 EUR
Change Today -0.054 / -1.72%
Volume 2.7K
ECX On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 5:15 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Uwe Bicker M.D., Ph.D.

Independent Director and Member of Strategy Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 30 board members in 2 different organizations across 4 different industries.

See Board Relationships
69€72,000

Background*

Prof. Dr. Uwe Bicker M.D., Ph.D. serves as the Professor of the Medical Faculty of the Heidelberg University. Prof. Dr. Bicker served as the Managing Director of Behringwerke AG. He serves as an Executive Chairman of Scil Holding GmbH. He has been Chairman of the Supervisory Board of Dade Behring Holding GmbH since December 31, 2005. He served as the Deputy Chairman of Supervisory Board at Epigenomics Ag until May 02, 2012. He has been an Independent Director at Sanofi ...

Read Full Background

Corporate Headquarters*

Kleine Präsidentenstrasse 1
Berlin, -- 10178

Germany

Phone: 49 30 243 450
Fax: 49 30 2434 5555

Board Members Memberships*

Former Non-Executive Director
Director and Member of Advisory Board
1999-N/A
Former Non-Executive Director, Member of Audit Committee and Member of Remuneration Committee
2008-Present
Independent Director and Member of Strategy Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€72,000
Total Calculated Compensation€72,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECX:GR €3.09 EUR -0.054

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIGENOMICS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.